tiprankstipranks
Advertisement
Advertisement

CLYM Stock Latest News

Climb Bio initiated with an Outperform at RBC Capital
The FlyClimb Bio initiated with an Outperform at RBC Capital
5h ago
CLYM
Climb Bio’s Budoprutug Trial Completion Sets Stage for Next Investor Catalyst
PremiumCompany Announcements
Climb Bio’s Budoprutug Trial Completion Sets Stage for Next Investor Catalyst
4d ago
CLYM
Climb Bio: Unique APRIL Inhibitor Profile Supports Buy Rating and Unchanged $20 Price Target
PremiumRatings
Climb Bio: Unique APRIL Inhibitor Profile Supports Buy Rating and Unchanged $20 Price Target
13d ago
CLYM
Climb Bio Appoints Breanna O’Reilly to Board
PremiumCompany Announcements
Climb Bio Appoints Breanna O’Reilly to Board
1M ago
8K
CLYM
Climb Bio Buy Rating Reiterated as Advancing Pipeline Supports Maintained $20 Price Target
PremiumRatings
Climb Bio Buy Rating Reiterated as Advancing Pipeline Supports Maintained $20 Price Target
1M ago
CLYM
Climb Bio Establishes New At-the-Market Equity Program
PremiumCompany AnnouncementsClimb Bio Establishes New At-the-Market Equity Program
2M ago
8K
CLYM
Climb Bio price target raised to $20 from $19 at BTIG
Premium
The Fly
Climb Bio price target raised to $20 from $19 at BTIG
2M ago
CLYM
Climb Bio announces initial data from budoprutug study at EHA
Premium
The Fly
Climb Bio announces initial data from budoprutug study at EHA
2M ago
CLYM
Climb Bio Reports Encouraging Early Budoprutug ITP Data
PremiumCompany Announcements
Climb Bio Reports Encouraging Early Budoprutug ITP Data
2M ago
8K
CLYM
Climb Bio Shareholders Approve Equity Plan Amendment, Reelect Directors
PremiumCompany Announcements
Climb Bio Shareholders Approve Equity Plan Amendment, Reelect Directors
2M ago
8K
CLYM
Climb Bio initiated with a Buy at Guggenheim
PremiumThe Fly
Climb Bio initiated with a Buy at Guggenheim
2M ago
AMGN
CLYM
Julian Harrison Reiterates Buy on CLYM116, Maintains $19 Price Target on Best-in-Class IgAN Potential
PremiumRatings
Julian Harrison Reiterates Buy on CLYM116, Maintains $19 Price Target on Best-in-Class IgAN Potential
2M ago
CLYM
Climb Bio Reports Positive Early-Stage Data for CLYM116
PremiumCompany AnnouncementsClimb Bio Reports Positive Early-Stage Data for CLYM116
2M ago
8K
CLYM
Climb Bio registers to sell 11.59M shares of common stock for holders
Premium
The Fly
Climb Bio registers to sell 11.59M shares of common stock for holders
2M ago
CLYM
Climb Bio price target raised to $20 from $15 at H.C. Wainwright
Premium
The Fly
Climb Bio price target raised to $20 from $15 at H.C. Wainwright
3M ago
CLYM
Climb Bio price target raised to $17 from $15 at Wedbush
PremiumThe Fly
Climb Bio price target raised to $17 from $15 at Wedbush
3M ago
CLYM
Climb Bio reports Q1 EPS (20c), consensus (31c)
PremiumThe Fly
Climb Bio reports Q1 EPS (20c), consensus (31c)
3M ago
CLYM
Climb Bio price target raised to $21 from $12 at Baird
PremiumThe Fly
Climb Bio price target raised to $21 from $12 at Baird
3M ago
CLYM
Climb Bio price target raised to $19 from $8 at BTIG
PremiumThe Fly
Climb Bio price target raised to $19 from $8 at BTIG
3M ago
CLYM
Climb Bio Highlights Budoprutug Progress at R&D Spotlight
PremiumCompany AnnouncementsClimb Bio Highlights Budoprutug Progress at R&D Spotlight
3M ago
8K
CLYM
Climb Bio initiated with a Buy at Chardan
Premium
The Fly
Climb Bio initiated with a Buy at Chardan
3M ago
CLYM
management to meet virtually with Piper Sandler
Premium
The Fly
management to meet virtually with Piper Sandler
3M ago
CLYM

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >